These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31267330)

  • 1. Infiltration by myeloperoxidase-positive neutrophils is an independent prognostic factor in breast cancer.
    Zeindler J; Angehrn F; Droeser R; Däster S; Piscuoglio S; Ng CKY; Kilic E; Mechera R; Meili S; Isaak A; Weber WP; Muenst S; Soysal SD
    Breast Cancer Res Treat; 2019 Oct; 177(3):581-589. PubMed ID: 31267330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor.
    Droeser RA; Hirt C; Eppenberger-Castori S; Zlobec I; Viehl CT; Frey DM; Nebiker CA; Rosso R; Zuber M; Amicarella F; Iezzi G; Sconocchia G; Heberer M; Lugli A; Tornillo L; Oertli D; Terracciano L; Spagnoli GC
    PLoS One; 2013; 8(5):e64814. PubMed ID: 23734221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil infiltration is a favorable prognostic factor in early stages of colon cancer.
    Wikberg ML; Ling A; Li X; Öberg Å; Edin S; Palmqvist R
    Hum Pathol; 2017 Oct; 68():193-202. PubMed ID: 28882699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status.
    Chung YR; Kim HJ; Jang MH; Park SY
    Breast Cancer Res Treat; 2017 Feb; 161(3):409-420. PubMed ID: 27913931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
    Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.
    Ohnstad HO; Borgen E; Falk RS; Lien TG; Aaserud M; Sveli MAT; Kyte JA; Kristensen VN; Geitvik GA; Schlichting E; Wist EA; Sørlie T; Russnes HG; Naume B
    Breast Cancer Res; 2017 Nov; 19(1):120. PubMed ID: 29137653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2 is a highly significant prognostic marker of hormone-receptor-positive, human epidermal growth factor receptor-2-negative breast cancer.
    Seong MK; Lee JY; Byeon J; Sohn YJ; Seol H; Lee JK; Kim EK; Kim HA; Noh WC
    Breast Cancer Res Treat; 2015 Feb; 150(1):141-8. PubMed ID: 25682076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004-2014).
    De Lara S; Nyqvist J; Werner Rönnerman E; Helou K; Kenne Sarenmalm E; Einbeigi Z; Karlsson P; Parris TZ; Kovács A
    BMC Cancer; 2019 Feb; 19(1):187. PubMed ID: 30819139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of CD9 expression differs between tumour cells and stromal immune cells, and depends on the molecular subtype of the invasive breast carcinoma.
    Kwon HJ; Choi JE; Kang SH; Son Y; Bae YK
    Histopathology; 2017 Jun; 70(7):1155-1165. PubMed ID: 28178752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
    Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
    BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence and significance of tumor-associated neutrophils in patients with colorectal cancer.
    Galdiero MR; Bianchi P; Grizzi F; Di Caro G; Basso G; Ponzetta A; Bonavita E; Barbagallo M; Tartari S; Polentarutti N; Malesci A; Marone G; Roncalli M; Laghi L; Garlanda C; Mantovani A; Jaillon S
    Int J Cancer; 2016 Jul; 139(2):446-56. PubMed ID: 26939802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort.
    Johansson ALV; Trewin CB; Hjerkind KV; Ellingjord-Dale M; Johannesen TB; Ursin G
    Int J Cancer; 2019 Mar; 144(6):1251-1261. PubMed ID: 30367449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic effects of abnormal DNA damage response protein expression in breast cancer.
    Suh KJ; Ryu HS; Lee KH; Kim H; Min A; Kim TY; Yang Y; Lee HB; Moon HG; Han SW; Oh DY; Han W; Park IA; Noh DY; Im SA
    Breast Cancer Res Treat; 2019 May; 175(1):117-127. PubMed ID: 30671767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role for the derived neutrophil-to-lymphocyte ratio in early breast cancer: a GEICAM/9906 substudy.
    Templeton AJ; Rodríguez-Lescure Á; Ruíz A; Alba E; Calvo L; Ruíz-Borrego M; Santaballa A; Rodríguez CA; Crespo C; Ramos M; Gracia-Marco JM; Lluch A; Álvarez I; Casas MI; Sánchez-Aragó M; Caballero R; Carrasco E; Amir E; Martin M; Ocaña A;
    Clin Transl Oncol; 2018 Dec; 20(12):1548-1556. PubMed ID: 29766456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes.
    Lattanzio R; Iezzi M; Sala G; Tinari N; Falasca M; Alberti S; Buglioni S; Mottolese M; Perracchio L; Natali PG; Piantelli M
    BMC Cancer; 2019 Jul; 19(1):747. PubMed ID: 31362705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer].
    Liu ZF; Chen C; Yao XL; Sun SR
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of the Expression of DNA Repair-Related Biomarkers Mediated by Alcohol in Gastric Cancer Patients.
    Zhang Y; Wu H; Yang F; Ning J; Li M; Zhao C; Zhong S; Gu K; Wang H
    Am J Pathol; 2018 Feb; 188(2):367-377. PubMed ID: 29331492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer.
    Egeland EV; Boye K; Park D; Synnestvedt M; Sauer T; ; Naume B; Borgen E; Mælandsmo GM
    Breast Cancer Res Treat; 2017 Feb; 162(1):127-137. PubMed ID: 28058579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4-1 and NRDP1, in primary breast cancer.
    Luhtala S; Staff S; Kallioniemi A; Tanner M; Isola J
    BMC Cancer; 2018 Oct; 18(1):1045. PubMed ID: 30367623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-L1 expression and tumor infiltrating PD-1+ lymphocytes associated with outcome in HER2+ breast cancer patients.
    Tsang JY; Au WL; Lo KY; Ni YB; Hlaing T; Hu J; Chan SK; Chan KF; Cheung SY; Tse GM
    Breast Cancer Res Treat; 2017 Feb; 162(1):19-30. PubMed ID: 28058578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.